Cette conférence de quatre jours organisée par le Réseau eurasien de réduction des risques (EHRN) servira de plateforme de discussion régionale avant la 25ème Conférence internationale sur la réduction des risques et la 22ème Conférence internationale sur le SIDA.

Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

Abonnez-vous à l'Alerte mensuelle de l'IDPC pour recevoir des informations relatives à la politique des drogues.

On 4-6 April 2017 Vilnius (Lithuania) will host a Regional Conference "HARM REDUCTION IN THE NEW ENVIRONMENT". The event is organized by the Eurasian Harm Reduction Network (EHRN) in the framework of the Regional Program "Harm Reduction Works – Fund It!" funded by the Global Fund to Fight AIDS, Tuberculosis and Malaria.

The Conference will gather representatives of governments and government agencies, NGOs and PWUD communities from Central and Eastern Europe and Central Asia (CEECA), as well as experts, donors and representatives of international organizations.

Participants will be able to assess the results, progress and prospects of the advocacy effort undertaken by civil society in order to achieve sustainable and quality harm reduction programs in CEECA. Another objective is to outline development strategies for harm reduction programs from the standpoint of civil society and the state. That is necessary for the establishment of a joint effort aimed at ensuring sustainability of these programs in CEECA in response to the new environment, primarily associated with the transition from donor to domestic funding. In this new environment, harm reduction provides a link between people who use drugs and the entire continuum of drug-related services, from HIV/TB prevention to testing, treatment of sexually transmitted diseases and hepatitis, as well as helping develop adherence to ART.

Over the course of three days, the Conference will tackle the main issues related to harm reduction in the new environment:

Day 2 – the role of harm reduction in social and medical care for people who use drugs;

Day 3 - harm reduction as health and human rights-based drug policy.

Civil society representatives, EHRN members and members of PWUD communities will get a unique opportunity to win 80 grants to take part in the Conference. An application form will be available on the EHRN website from the 12th of December.

Keep up-to-date with drug policy developments by subscribing to the IDPC Monthly Alert.

La réduction des risques dans le nouveau contexte

Les décisions récentes prises par le gouvernement canadien concernant la réduction des peines, les opiacés, le cannabis et les condamnations signalent qu'une nouvelle approche à la gestion de la consommation des drogues illicites au Canada se dessine.

En même temps, le nouveau gouvernement des États-Unis promet de renforcer un régime antidrogue déjà punitif ayant comme conséquences des efforts de contrôle à l'étranger en plus de politiques de cannabis dans plusieurs États américains.

Ce paysage en rapide évolution fait en sorte que c'est maintenant le moment idéal pour rassembler les voix d'experts provenant de partout au pays afin de projeter le paysage de la prochaine décennie et d'aider à identifier de nouvelles opportunités et directions pour les politiques sur les drogues au Canada.

Joignez-vous à nous les 4 et 5 avril 2017 alors que plus de 120 chercheurs, décideurs politiques, responsables de la santé publique, forces de l'ordre, consommateurs de drogue et organisateurs se rencontreront à Ottawa pour examiner l'avenir des politiques antidrogues nationales et internationales et proposer une série de nouvelles orientations.

Venez écouter plus d'une douzaine d'orateurs et participer à quatre groupes de discussion pour aider la création de recommandations concernant :

Contrôle et gestion au niveau international

Décriminalisation, réglementation et réduction des peines

Intégration des services de police et de la santé publique

Stratégies d'équité sociale et en sante

Cliquez ici pour plus d'informations sur l'événement

Forum sur l'avenir des drogues au Canada

La Conférence sera dédiée aux résultats, aux leçons apprises, et aux perspectives d’un plaidoyer de la société civile axé sur la communauté, pour des programmes de réduction des risques qui soient durables et de qualité. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

The economic and political factors of the current decade of the XXI century are shaping the new environment for health and social policies in the region of Central and Eastern Europe and Central Asia (CEECA). A clear tendency is being observed of decrease in funding, available from international and bilateral donors for middle-income countries on the health related responses, including for HIV, hepatitis C and tuberculosis. Though, at the same time, the economies of the region are growing, countries are not yet well prepared for ensuring sustainable transition from donor support to national funding of health programs, especially those targeted at key affected populations (KAPs), and face serious challenges.

The new environment, identified first of all by transition from external support to domestic resources, dictates new approaches in addressing health and social problems of KAPs and clearly assessing the transition consequences for the region, governments, communities, and donors on the one hand, and for sustainability of harm reduction services on the other.

Harm reduction services in CEECA during last years were seen mainly as HIV prevention, but in the new environment they are playing the role of a vehicle, which allows people using drugs to access all continuum of services from prevention information to testing for HIV and tuberculosis, STI and hepatitis treatment, and development of adherence to ARV treatment. In the new circumstances, harm reduction has to be integrated into health and social care systems and needs to be recognized by governments and local communities as essential for achieving social changes.

Conférence régionale de 2017 sur la réduction des risques dans l’EOCAC 

Cet événement visera à combler le fossé entre la recherche, la réduction des risques, le traitement et les personnes qui vivent avec l’hépatite C.

The summit will bring together medical experts, researcherand representatives of harm reduction and community services to discuss the needs, gaps and opportunities to make treatment available for all people in need. Also to present community approaches for testing and treatment for HCV (and B) and to discuss/agree on further community action and advocacy.

To provide a platform for all those involved in HCV treatment

To create synergy with the International Lever Congress conference and its attendees

To develop an enduring cooperation in building the road to eradication

To launch a consensus statement on community inclusion

Sommet communautaire sur l’hépatite C

A Psychedelic Science 2017, la communauté scientifique internationale se rencontrera pour partager et découvrir les nouvelles recherches sur les avantages et les risques des psychédéliques et des composés connexes.

At Psychedelic Science 2017, the international scientific community will come together at the Oakland Marriott City Center in Oakland, Calif., to share and discover new research into the benefits and risks of MDMA, LSD, psilocybin, ayahuasca, ketamine, ibogaine, medical marijuana, and more.

Please join us for this historic six-day global gathering, featuring three days of conference presentations and three days of workshops, a Sunset Cruise on the San Francisco Bay, the world's first Psychedelic Comedy Banquet, and much more.

Psychedelic Science 2017

La 61ème Session de la CICAD couvrira un large éventail de sujets sur la réduction de la demande et de l’offre. Pour en savoir plus, en anglais, veuillez lire les informations ci-dessous.

We would like to inform you that the 61st Regular Session of the Inter-American Drug Abuse Control Commission (CICAD) will take place on April 24-26, 2017 in Washington, DC. Please find attached the draft agenda and the information bulletin of the event.

that would like to attend the 61th Regular Session of CICAD should send a letter addressed to the Secretary General of the OAS, expressing their interest to attend, and the names of the representatives of the organization (maximum of 2) to the email address civilsociety@oas.com 

Please take into account that civil society representatives will be responsible for covering their own expenses related to their stay in Washington DC, including accommodation, transportation, meals and other incidentals.

For more information about the 61th Regular Session of CICAD, please visit the CICAD Website (http://www.cicad.oas.org).

Événements

La réduction des risques dans le nouveau contexte

Forum sur l'avenir des drogues au Canada

Conférence régionale de 2017 sur la réduction des risques dans l’EOCAC

Sommet communautaire sur l’hépatite C

Psychedelic Science 2017

61ème Session ordinaire de la Commission interaméricaine contre l’abus des drogues (CICAD)